Drug intelligence / Profile preview

measles vaccine (live attenuated)

Development stage
Unknown
Lead developer
Oncovita
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Measovir is a live attenuated measles vaccine developed and manufactured by the Serum Institute of India. It contains the Edmonston-Zagreb strain of the measles virus, which has been attenuated through serial passage in human diploid cells. The vaccine is indicated for the active immunization of children and adults against measles. Upon administration, the attenuated virus replicates minimally, mimicking a natural infection to elicit a robust and long-lasting immune response, including the production of IgG antibodies and the activation of T-lymphocytes. It is typically supplied as a lyophilized powder that must be reconstituted with a sterile diluent before subcutaneous injection.

Brand names
Measovir
Other names
measles vaccinelive attenuated measles vaccine
02

Targets

SLAMF1 (Signaling lymphocytic activation molecule family member 1)CD46 (CD46 Molecule)

Beyond the preview

Go deeper on measles vaccine (live attenuated).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on measles vaccine (live attenuated).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call